Loomis, Sayles & Company
GRDN

Loomis, Sayles & Company’s Guardian Pharmacy Services GRDN Stock Holding History

Loomis, Sayles & Company’s Portfolio GRDN Stock Details GRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.4M Sell
869,836
-61,853
-7% -$2.39M 0.05% 159
2026
Q1 		$35.1M Buy
931,689
+296,068
+47% +$9.67M 0.05% 143
2025
Q4 		$19.1M Buy
+635,621
New +$18M 0.02% 243

Other funds holding GRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
VCM
Valiant Capital Management San Francisco, California $2.48B AUM 57.08% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Loomis, Sayles & Company's GRDN Position: Q2 2026 in Review

Loomis, Sayles & Company reduced its Guardian Pharmacy Services (GRDN) stake by 6.6% in Q2 2026, selling an estimated $2.39M and leaving 869,836 shares worth $36.4M. The position accounts for 0.05% of the portfolio, ranked #159.

Loomis, Sayles & Company first reported a position in GRDN in Q4 2025 and has held it in 3 quarters since. 190 funds tracked by Wall St. Rank hold GRDN as of Q2 2026.

  • Loomis, Sayles & Company held 869,836 shares of Guardian Pharmacy Services worth $36.4M as of Q2 2026.
  • Loomis, Sayles & Company sold 61,853 Guardian Pharmacy Services shares in Q2 2026, an estimated $2.39M.
  • Guardian Pharmacy Services made up 0.05% of Loomis, Sayles & Company's portfolio in Q2 2026, its #159 holding.
  • Loomis, Sayles & Company first reported a position in Guardian Pharmacy Services in Q4 2025 and has held it in 3 quarters since.
  • 190 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q2 2026.

Based on Loomis, Sayles & Company's 13F filing for Q2 2026, filed 14 Aug 2026.